How to cite item

Twice-daily chemoradiotherapy must still be the choice for patients with limited-stage small-cell lung cancer

   
@article{JTD15547,
	author = {Fernando Franco and David Pérez-Callejo and Mariano Provencio},
	title = {Twice-daily chemoradiotherapy must still be the choice for patients with limited-stage small-cell lung cancer},
	journal = {Journal of Thoracic Disease},
	volume = {9},
	number = {9},
	year = {2017},
	keywords = {},
	abstract = {At the time of diagnosis, 30% of patients with small cell lung carcinoma (SCLC) present a limited stage of disease, which is now called I-IIIB (IASLC). However, the outcome of limited-stage SCLC remains poor, with a median survival of 16 to 24 months using current treatments, and only 15–25% of long-term survivors.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/15547}
}